Prop Nimbus has announced an exciting poker tournament set to take place on January 11th, and sign-ups are rolling in fast! Traders and poker lovers are eager to join in for a chance to win incredible prizes, including funded evaluation accounts.
The tournament, hosted online via Poker Now, is a unique opportunity for participants to showcase their poker skills while also getting a shot at advancing their trading careers with Prop Nimbus. The stakes are high, with evaluations for prop trading accounts up for grabs, making this event a must-join for anyone serious about both poker and trading.
Join Prop Nimbus Poker Tournament on January 11th
Here’s what’s at stake for the top players:
- 1st Place: A 25k evaluation account
- 2nd Place: A 10k evaluation account
- 3rd Place: A 5k evaluation account
These evaluations will allow the winners to demonstrate their trading prowess under real market conditions, giving them the potential to earn even more through Prop Nimbus’ funded trader program.
To participate, players must ensure their usernames on Poker Now match their Discord accounts, as this is required for verification purposes. It’s also important to note that only one entry per person is allowed—no exceptions. This rule ensures fair competition and makes sure everyone has a single shot at these lucrative prizes.
For those who haven’t signed up yet, there’s still time. Don’t miss out on your chance to compete in a fun, fast-paced poker tournament that could lead to real trading opportunities.
To register, follow this link: Poker Now Tournament Sign-Up, and get ready to test your skills at the table!
Who will walk away with the top prize? Join the table and find out! Click here to join Prop Nimbus Discord.
About the Firm
Here are some interesting facts about the firm:
- First Payout After 14 Calendar Days
- Bi-weekly Future Payouts
- Profit Share of 90%
- Overnight & Weekend Holding Allowed
- News Trading Allowed
- Balance-based Drawdown
Also, use our Discount Code (FOREXPROPREVIEWS) for a 20% Discount or read the Review.